[1]SIEGEL RL, MILLER KD, JEMAL A.Cancer Statistics, 2016[J].CA Cancer J Clin, 2016, 66 (1) :7-30.
|
[2]HUANG J.Current progress in epigenetic research for hepatocarcinomagenesis[J].Sci China C Life Sci, 2009, 52 (1) :31-42.
|
[3]ZHAO LJ, LI ZF, SHI RY, et al.Expression of NOB1 in liver cancer tissues and its significance[J].J Clin Hepatol, 2016, 32 (4) :739-741. (in Chinese) .赵丽娟, 李志锋, 石荣亚, 等.NOB1在肝癌组织中的表达及意义[J].临床肝胆病杂志, 2016, 32 (4) :739-741.
|
[4]BARTEL DP.Micrornas:genomics, biogenesis, mechanism, and function[J].Cell, 2004, 116 (2) :281-297.
|
[5]PASQUINELLI AE.Micrornas and their targets:recognition, regulation and an emerging reciprocal relationship[J].Nat Rev Genet, 2012, 13 (4) :271-282.
|
[6]HWANG HW, MENDELL JT.Micrornas in cell proliferation, cell death, and tumorigenesis[J].Br J Cancer, 2006, 94 (6) :776-780.
|
[7]SCHICKEL R, BOYERINAS B, PARK SM, et al.Micrornas:key players in the immune system, differentiation, tumorigenesis and cell death[J].Oncogene, 2008, 27 (45) :5959-5974.
|
[8]MENDELL JT.Micrornas:critical regulators of development, cellular physiology and malignancy[J].Cell Cycle, 2005, 4 (9) :1179-1184.
|
[9]LI ZW, WU T, FU YX, et al.Expression and roles of MicroRNA-31 in HCC[J].Chin J Clin Pharmacol Ther, 2015, 20 (10) :1098-1101. (in Chinese) 李中文, 吴涛, 付应霄, 等.MicroRNA-31在肝癌中的表达和作用[J].中国临床药理学与治疗学, 2015, 20 (10) :1098-1101.
|
[10]JIN L, LI Y, LIU J, et al.Tumor suppressor mir-149-5p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma[J].Mol Med Rep, 2016, 13 (6) :5386-5392.
|
[11]XU K, LIU X, MAO X, et al.Microrna-149 suppresses colorectal cancer cell migration and invasion by directly targeting forkhead box transcription factor foxm1[J].Cell Physiol Biochem, 2015, 35 (2) :499-515.
|
[12]CHAN SH, HUANG WC, CHANG JW, et al.Microrna-149 targets git1 to suppress integrin signaling and breast cancer metastasis[J].Oncogene, 2014, 33 (36) :4496-4507.
|
[13] SCHMITTGEN TD, LIVAK KJ.Analyzing Real-Time PCR data by the comparative C (T) method[J].Nat Protoc, 2008, 3 (6) :1101-1108.
|
[14]WONG CM, NG IO.Molecular pathogenesis of hepatocellular carcinoma[J].Liver Int, 2008, 28 (2) :160-174.
|
[15]MORENO-MOYA JM, VILELLA F, SIMON C.Microrna:key gene expression regulators[J].Fertil Steril, 2014, 101 (6) :1516-1523.
|
[16]CALIN GA, CROCE CM.Microrna signatures in human cancers[J].Nat Rev Cancer, 2006, 6 (11) :857-866.
|
[17]MEDINA PP, SLACK FJ.Micrornas and cancer:an overview[J].Cell Cycle, 2008, 7 (16) :2485-2492.
|
[18]NIKITINA EG, URAZOVA LN, STEGNY VN.Micrornas and human cancer[J].Exp Oncol, 2012, 34 (1) :2-8.
|
[19]FARAZI TA, HOELL JI, MOROZOV P, et al.Micrornas in human cancer[J].Adv Exp Med Biol, 2013, 774:1-20.
|
[20]SHENOUDA SK, ALAHARI SK.Microrna function in cancer:oncogene or a tumor suppressor?[J].Cancer Metastasis Rev, 2009, 28 (3-4) :369-378.
|
[21]FENG M, E CY, LI H, et al.Expression of miR-196a in liver cancer cells and its promotion effect on proliferation[J].J Jilin Univ:Med Edit, 2015, 41 (1) :120-124. (in Chinese) 冯默, 鄂长勇, 李航, 等.MiR-196a在肝细胞癌中的表达及其促增殖作用[J].吉林大学学报:医学版, 2015, 41 (1) :120-124.
|
[22]NANA-SINKAM SP, CROCE CM.Micrornas as therapeutic targets in cancer[J].Transl Res, 2011, 157 (4) :216-225.
|